ArticleBMC public health2026
Awareness, knowledge, and practices related to hepatitis B and hepatitis C in the Republic of Uzbekistan-Results from a population-based survey, 2022.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatient and healthcare provider knowledge were previously found to be significantly associated with viral hepatitis testing in Uzbekistan. However, no survey has assessed awareness and knowledge of viral hepatitis among the general population.
methodsIn 2022, we conducted a cross-sectional population-based survey among persons aged≥18 years in seven of Uzbekistan's 14 regions representing 60% of the population. We conducted face-to-face interviews to assess hepatitis B and C awareness, knowledge, and related practices. Knowledge scores for hepatitis B and C were calculated based on the total number of correct answers. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were computed to assess factors associated with awareness and knowledge scores. Analyses were weighted.
resultsOf 10,000 targeted adults, 9,066 (91%) participated in the survey. Overall, 54.7% (95% CI: 46.4-62.8) and 39.0% (95% CI: 33.0-45.4) were aware of hepatitis B and hepatitis C, respectively. Females compared to males (hepatitis B: aOR: 2.61 (95% CI: 1.91-3.56); hepatitis C: 2.15 (1.76-2.63)) and persons with higher education compared to those with technical education (hepatitis B: aOR: 1.89 (95% CI:1.32-2.71); hepatitis C: 2.30 (1.63-3.25)) had higher hepatitis B and hepatitis C awareness. The median knowledge scores for hepatitis B and hepatitis C transmission were 4.9 (IQR: 4.2-6.3) out of nine and 4.8 (IQR: 4.2-5.9) out of eight, respectively. Median knowledge scores for prevention methods were 1.7 (IQR: 1.2-2.4) and 2.3 (IQR: 0.7-2.9) out of five for hepatitis B and hepatitis C, respectively. Persons ≥50 years old compared to 18-29 years old and those with less than secondary education compared to those with technical education had lower knowledge scores for hepatitis B. Living outside of Tashkent city and being unemployed were associated with having lower knowledge scores for hepatitis C. Overall,28.8% reported having ever been tested for hepatitis B and 17.7% for hepatitis C; while 8.2% and 2.3% reported being told that they have hepatitis B and hepatitis C, respectively.
conclusionsEducational campaigns are needed to promote population awareness and address knowledge gaps to increase uptake of interventions aimed at eliminating viral hepatitis in Uzbekistan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.